The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis

BACKGROUND: It remains uncertain whether smoking status can effect efficacy of immune checkpoint inhibitors (ICIs) in metastatic non-small cell lung cancer (NSCLC). We performed a meta-analysis to address this issue. PATIENTS AND METHODS: PubMed, Embase, Cochrane Library, Web of Science, and interna...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Linzheng, Jin, Bo, Liu, Tingting, Chen, Jun, Li, Guang, Dang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413256/
https://www.ncbi.nlm.nih.gov/pubmed/34505024
http://dx.doi.org/10.1016/j.eclinm.2021.100990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413256/
https://www.ncbi.nlm.nih.gov/pubmed/34505024
http://dx.doi.org/10.1016/j.eclinm.2021.100990

Ejemplares similares